Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Clinical
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Immuno-oncology
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Therapy areas
Immuno-oncology
Immuno-oncology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-oncology
Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell...
Biospace News
-
February 26, 2021
Immuno-oncology
Puma Biotechnology and Pierre Fabre Amend NERLYNX License Agreement to Include Greater China – FirstWord Pharma
Immuno-oncology
Daiichi Sankyo and LYSA-LYSARC-CALYM Enter Research Collaboration for Valemetostat in Patients with Relapsed/Refractory B-Cell Lymphoma – FirstWord Pharma
Immuno-oncology
BioSpace Movers & Shakers, Feb. 26
Immuno-oncology
Mersana Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Immuno-oncology
National Marrow Donor Program/Be The Match Announce Plan to Launch ACCESS...
Biospace News
-
February 25, 2021
0
Immuno-oncology
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results...
Globenewswire News
-
February 25, 2021
0
Immuno-oncology
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and...
Globenewswire News
-
February 25, 2021
0
Immuno-oncology
BioSpace Global Roundup: UCB and Microsoft Pair AI and Drug Discovery...
Biospace News
-
February 25, 2021
0
Immuno-oncology
BMS, bluebird Publish Ide-Cel Data in NEJM, One Month Ahead of...
Biospace News
-
February 25, 2021
0
1
2
3
...
80
Page 1 of 80
- Advertisement -
MOST POPULAR
Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed’s Oral Insulin...
March 26, 2019
First Participant Enrolled in Second Cohort of BiondVax’s Pivotal, Clinical Efficacy,...
July 8, 2019
Sartorius Supervisory Board Appoints Two New Executive Board Members
December 6, 2018
BioIntervene Announces $30 Million Series A Financing
January 6, 2020
Load more
HOT NEWS
Commercial
Trillium Therapeutics to Unveil its STING Agonist Program at the AACR...
Commercial
Clovis Oncology to Present at the Bank of America Merrill Lynch...
Phase I
Sangamo Announces Preliminary Results From the First Three Patients in a...
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
